{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:36:13Z","timestamp":1792888573094,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.bcp.2026.118027","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:46:40Z","timestamp":1777564000000},"page":"118027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Bosentan confers cardioprotection against cisplatin toxicity: Involvement of \u03b2-arrestin-linked ETA receptor signaling"],"prefix":"10.1016","volume":"250","author":[{"given":"Hnin Ei Ei","family":"Khine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supachoke","family":"Mangmool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7851-2477","authenticated-orcid":false,"given":"Warisara","family":"Parichatikanond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.118027_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.119906","article-title":"Mitochondrial quality control: biochemical mechanism of cardiovascular disease","volume":"1872","author":"Inferrera","year":"2025","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"issue":"2","key":"10.1016\/j.bcp.2026.118027_b0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1254\/jphs.13R02CR","article-title":"Endothelin receptor signaling: new insight into its regulatory mechanisms","volume":"123","author":"Horinouchi","year":"2013","journal-title":"J. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118027_b0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pharmthera.2014.05.013","article-title":"Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: therapeutic perspectives","volume":"144","author":"Javadov","year":"2014","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2026.118027_b0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/biom11010009","article-title":"Beta-arrestins and receptor signaling in the vascular endothelium","volume":"11","author":"Lee","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bcp.2026.118027_b0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.yjmcc.2010.11.005","article-title":"\u03b2-Arrestin: a signaling molecule and potential therapeutic target for heart failure","volume":"51","author":"Noor","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"9","key":"10.1016\/j.bcp.2026.118027_b0030","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1172\/JCI11753","article-title":"Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes","volume":"107","author":"Ishibashi","year":"2001","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcp.2026.118027_b0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/nchembio.2527","article-title":"Structure-inspired design of \u03b2-arrestin-biased ligands for aminergic GPCRs","volume":"14","author":"McCorvy","year":"2018","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118027_b0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00018-010-0518-0","article-title":"Endothelin","volume":"68","author":"Kawanabe","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"issue":"50","key":"10.1016\/j.bcp.2026.118027_b0045","doi-asserted-by":"crossref","first-page":"49929","DOI":"10.1074\/jbc.M306930200","article-title":"Endothelin-1 activates endothelial cell nitric-oxide synthase via heterotrimeric G-protein \u03b2\u03b3 subunit signaling to protein kinase B\/Akt","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2026.118027_b0050","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1146\/annurev.pharmtox.47.120505.105134","article-title":"Contrasting actions of endothelin ETA and ETB receptors in cardiovascular disease","volume":"47","author":"Schneider","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"20","key":"10.1016\/j.bcp.2026.118027_b0055","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.3390\/cells13201674","article-title":"Regulation of \u03b2-adrenergic receptors in the heart: a review on emerging therapeutic strategies for heart failure","volume":"13","author":"Parichatikanond","year":"2024","journal-title":"Cells"},{"issue":"22","key":"10.1016\/j.bcp.2026.118027_b0060","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/CIRCULATIONAHA.117.028194","article-title":"Biased G protein-coupled receptor signaling: changing the paradigm of drug discovery","volume":"137","author":"Wisler","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2026.118027_b0065","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23777","article-title":"Phosphorylation of \u03b2-arrestin2 at Thr(383) by MEK underlies \u03b2-arrestin-dependent activation of Erk1\/2 by GPCRs","volume":"6","author":"Cassier","year":"2017","journal-title":"Elife"},{"issue":"5","key":"10.1016\/j.bcp.2026.118027_b0070","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1161\/CIRCRESAHA.116.304682","article-title":"Mitochondrial reprogramming induced by CaMKII\u03b4 mediates hypertrophy decompensation","volume":"116","author":"Westenbrink","year":"2015","journal-title":"Circ. Res."},{"issue":"5","key":"10.1016\/j.bcp.2026.118027_b0075","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1113\/JP275418","article-title":"Protein kinase D activation induces mitochondrial fragmentation and dysfunction in cardiomyocytes","volume":"596","author":"Jhun","year":"2018","journal-title":"J. Physiol."},{"key":"10.1016\/j.bcp.2026.118027_b0080","doi-asserted-by":"crossref","first-page":"853","DOI":"10.3389\/fcell.2020.00853","article-title":"Opa1 reduces hypoxia-induced cardiomyocyte death by improving mitochondrial quality control","volume":"8","author":"Xin","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118027_b0085","first-page":"19","article-title":"Regulation of mitochondrial ATP synthase in cardiac pathophysiology","volume":"5","author":"Long","year":"2015","journal-title":"Am. J. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.bcp.2026.118027_b0090","doi-asserted-by":"crossref","first-page":"479","DOI":"10.21037\/atm-21-503","article-title":"Constitutive activation of ERK1\/2 signaling protects against myocardial ischemia via inhibition of mitochondrial fragmentation in the aging heart","volume":"9","author":"Zhao","year":"2021","journal-title":"Ann. Transl. Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.118027_b0095","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.RES.85.10.940","article-title":"Regulation of bcl-2 family proteins during development and in response to oxidative stress in cardiac myocytes: association with changes in mitochondrial membrane potential","volume":"85","author":"Cook","year":"1999","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.bcp.2026.118027_b0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s10495-012-0741-2","article-title":"\u03b2-Arrestin prevents cell apoptosis through pro-apoptotic ERK1\/2 and p38 MAPKs and anti-apoptotic Akt pathways","volume":"17","author":"Yang","year":"2012","journal-title":"Apoptosis"},{"issue":"6","key":"10.1016\/j.bcp.2026.118027_b0105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/CIRCHEARTFAILURE.111.962571","article-title":"Cardiorenal actions of TRV120027, a novel \u03b2-arrestin-biased ligand at the angiotensin II type I receptor, in healthy and heart failure canines: a novel therapeutic strategy for acute heart failure","volume":"4","author":"Boerrigter","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.bcp.2026.118027_b0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lfs.2016.02.069","article-title":"Evidence for biased agonists and antagonists at the endothelin receptors","volume":"159","author":"Maguire","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2026.118027_b0115","doi-asserted-by":"crossref","unstructured":"H.E.E. Khine, S. Mangmool, W. Parichatikanond, Ambrisentan attenuates cisplatin-related mitochondrial dysfunction in the heart via regulation of p53 and NF-\u03baB signaling, Sci. Rep. (2026) [In Press].","DOI":"10.1038\/s41598-026-44822-9"},{"issue":"3","key":"10.1016\/j.bcp.2026.118027_b0120","first-page":"651","article-title":"Endothelin-1 and type III collagen alterations in the heart of rats following cisplatin-induced toxicity","volume":"5","author":"Huang","year":"2012","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2026.118027_b0125","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.bbamcr.2014.11.015","article-title":"H9c2 and HL-1 cells demonstrate distinct features of energy metabolism, mitochondrial function and sensitivity to hypoxia-reoxygenation","volume":"1853","author":"Kuznetsov","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2026.118027_b0130","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3389\/fphar.2020.00805","article-title":"Stimulation of GLP-1 receptor inhibits methylglyoxal-induced mitochondrial dysfunctions in H9c2 cardiomyoblasts: potential role of Epac\/PI3K\/Akt pathway","volume":"11","author":"Nuamnaichati","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118027_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116552","article-title":"Exendin-4 exhibits cardioprotective effects against high glucose-induced mitochondrial abnormalities: potential role of GLP-1 receptor and mTOR signaling","volume":"229","author":"Parichatikanond","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118027_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178233","article-title":"Exendin-4 improves mitochondrial integrity against cisplatin-induced cardiac damage: targeting p53 and NF-\u03baB pathways","volume":"1007","author":"Khine","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2026.118027_b0145","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10157-024-02490-x","article-title":"An integrated view of cisplatin-induced nephrotoxicity, hepatotoxicity, and cardiotoxicity: characteristics, common molecular mechanisms, and current clinical management","volume":"28","author":"Oliveira","year":"2024","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.bcp.2026.118027_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104846","article-title":"Mitophagy inhibitor liensinine suppresses doxorubicin-induced cardiotoxicity through inhibition of Drp1-mediated maladaptive mitochondrial fission","volume":"157","author":"Liang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"20","key":"10.1016\/j.bcp.2026.118027_b0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121900","article-title":"Stress response protein GJA1-20k promotes mitochondrial biogenesis, metabolic quiescence, and cardioprotection against ischemia\/reperfusion injury","volume":"3","author":"Basheer","year":"2018","journal-title":"JCI Insight"},{"issue":"22","key":"10.1016\/j.bcp.2026.118027_b0160","doi-asserted-by":"crossref","first-page":"13816","DOI":"10.3390\/ijms232213816","article-title":"High glucose-induced cardiomyocyte damage involves interplay between endothelin ET-1\/ETA\/ETB receptor and mTOR pathway","volume":"23","author":"Pandey","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118027_b0165","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(01)01434-0","article-title":"Endothelin-1 stimulates cardiomyocyte injury during mitochondrial dysfunction in culture","volume":"431","author":"Yuki","year":"2001","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118027_b0170","doi-asserted-by":"crossref","first-page":"595","DOI":"10.5483\/BMBRep.2019.52.10.206","article-title":"Endothelial-specific deletion of Ets-1 attenuates angiotensin II-induced cardiac fibrosis via suppression of endothelial-to-mesenchymal transition","volume":"52","author":"Xu","year":"2019","journal-title":"BMB Rep."},{"issue":"12","key":"10.1016\/j.bcp.2026.118027_b0175","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.3390\/jcm11123547","article-title":"Upregulation of endothelin-1 may predict chemotherapy-induced cardiotoxicity in women with breast cancer","volume":"11","author":"Krishnarao","year":"2022","journal-title":"J. Clin. Med."},{"issue":"10","key":"10.1016\/j.bcp.2026.118027_b0180","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/01.CIR.0000140766.52771.6D","article-title":"Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes","volume":"110","author":"Xu","year":"2004","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.bcp.2026.118027_b0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jmcb\/mjs002","article-title":"Cardiac-specific knockout of ETA receptor mitigates low ambient temperature-induced cardiac hypertrophy and contractile dysfunction","volume":"4","author":"Zhang","year":"2012","journal-title":"J. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118027_b0190","doi-asserted-by":"crossref","first-page":"271","DOI":"10.4149\/gpb_2012_031","article-title":"The influence of ETA and ETB receptor blockers on LPS-induced oxidative stress and NF-\u03baB signaling pathway in heart","volume":"31","author":"Piechota-Polanczyk","year":"2012","journal-title":"Gen. Physiol. Biophys."},{"issue":"4","key":"10.1016\/j.bcp.2026.118027_b0195","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/FJC.0000000000000283","article-title":"Vascular effects of endothelin receptor antagonists depend on their selectivity for ETA versus ETB receptors and on the functionality of endothelial ETB receptors","volume":"66","author":"Iglarz","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2026.118027_b0200","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tox.2005.11.022","article-title":"Selective endothelin A (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury","volume":"219","author":"Ozdemir","year":"2006","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/j.bcp.2026.118027_b0205","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejheart.2004.08.001","article-title":"Comparison of selective ETA and ETB receptor antagonists in patients with chronic heart failure","volume":"7","author":"Cowburn","year":"2005","journal-title":"Eur. J. Heart Fail."},{"issue":"3","key":"10.1016\/j.bcp.2026.118027_b0210","first-page":"484","article-title":"Dual endothelin receptor antagonists contrast the effects induced by endothelin-1 on cultured human microvascular endothelial cells","volume":"35","author":"Soldano","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"11","key":"10.1016\/j.bcp.2026.118027_b0215","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003381","article-title":"Dual endothelin-A\/endothelin-B receptor blockade and cardiac remodeling in heart failure with preserved ejection fraction","volume":"9","author":"Valero-Munoz","year":"2016","journal-title":"Circ. Heart Fail."},{"issue":"5","key":"10.1016\/j.bcp.2026.118027_b0220","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/j.1476-5381.1995.tb13296.x","article-title":"Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats","volume":"114","author":"Watanabe","year":"1995","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2026.118027_b0225","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.34067\/KID.0005462020","article-title":"G protein- and \u03b2-arrestin signaling profiles of endothelin derivatives at the type a endothelin receptor","volume":"2","author":"Xiong","year":"2021","journal-title":"Kidney 360."},{"issue":"5","key":"10.1016\/j.bcp.2026.118027_b0230","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.3390\/ijms24054475","article-title":"Endothelin-1 induces cell proliferation and myofibroblast differentiation through the ETAR\/G\u03b1q\/ERK signaling pathway in human cardiac fibroblasts","volume":"24","author":"Duangrat","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2026.118027_b0235","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1210\/en.2018-00705","article-title":"Scaffold proteins: from coordinating signaling pathways to metabolic regulation","volume":"159","author":"Mugabo","year":"2018","journal-title":"Endocrinology"},{"issue":"17","key":"10.1016\/j.bcp.2026.118027_b0240","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.7150\/thno.26619","article-title":"Pepducin-mediated cardioprotection via \u03b2-arrestin-biased \u03b22-adrenergic receptor-specific signaling","volume":"8","author":"Grisanti","year":"2018","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.bcp.2026.118027_b0245","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/CIRCULATIONAHA.116.024482","article-title":"Long-term biased \u03b2-arrestin signaling improves cardiac structure and function in dilated cardiomyopathy","volume":"135","author":"Ryba","year":"2017","journal-title":"Circulation"},{"issue":"19","key":"10.1016\/j.bcp.2026.118027_b0250","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.3390\/ijms251910297","article-title":"GQ262 attenuates pathological cardiac remodeling by downregulating the Akt\/mTOR signaling pathway","volume":"25","author":"Ma","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.118027_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175780","article-title":"G\u03b1q protein-biased ligand of angiotensin II type 1 receptor mediates myofibroblast differentiation through TGF-\u03b21\/ERK axis in human cardiac fibroblasts","volume":"951","author":"Parichatikanond","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118027_b0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.yjmcc.2014.02.009","article-title":"\u03b2-adrenergic receptor-mediated transactivation of epidermal growth factor receptor decreases cardiomyocyte apoptosis through differential subcellular activation of ERK1\/2 and Akt","volume":"72","author":"Grisanti","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118027_b0265","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1159\/000493037","article-title":"PI3K-AKT pathway protects cardiomyocytes against hypoxia-induced apoptosis by MitoKATP-mediated mitochondrial translocation of pAKT","volume":"49","author":"Song","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"16","key":"10.1016\/j.bcp.2026.118027_b0270","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","article-title":"MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo","volume":"109","author":"Lips","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.bcp.2026.118027_b0275","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1161\/01.CIR.101.6.660","article-title":"Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart","volume":"101","author":"Fujio","year":"2000","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.bcp.2026.118027_b0280","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3390\/jcdd12070266","article-title":"MAPK, PI3K\/Akt pathways, and GSK-3\u03b2 activity in severe acute heart failure in intensive care patients: an updated review","volume":"12","author":"Meco","year":"2025","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"10.1016\/j.bcp.2026.118027_b0285","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2014.08.006","article-title":"\u03b2-Arrestins regulate human cardiac fibroblast transformation and collagen synthesis in adverse ventricular remodeling","volume":"76","author":"Li","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"12","key":"10.1016\/j.bcp.2026.118027_b0290","first-page":"1579","article-title":"Regulation of mitochondrial oxidative stress by \u03b2-arrestins in cultured human cardiac fibroblasts","volume":"8","author":"Philip","year":"2015","journal-title":"Dis. Model. Mech."},{"issue":"21","key":"10.1016\/j.bcp.2026.118027_b0295","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1074\/jbc.A111.247726","article-title":"Gq protein-induced apoptosis is mediated by AKT kinase inhibition that leads to protein kinase C-induced c-Jun N-terminal kinase activation","volume":"292","author":"Ben-Ami","year":"2017","journal-title":"J. Biol. Chem."},{"issue":"28","key":"10.1016\/j.bcp.2026.118027_b0300","doi-asserted-by":"crossref","first-page":"E4107","DOI":"10.1073\/pnas.1606267113","article-title":"\u03b2-Arrestin-biased signaling through the \u03b22-adrenergic receptor promotes cardiomyocyte contraction","volume":"113","author":"Carr","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226003606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:30:34Z","timestamp":1792888234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226003606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":60,"alternative-id":["S0006295226003606"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118027","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bosentan confers cardioprotection against cisplatin toxicity: Involvement of \u03b2-arrestin-linked ETA receptor signaling","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118027"}}